Marek Pruszyński - Search Results

Year	Number of Results
2008	1
2010	1
2011	1
2012	2
2013	1
2014	6
2015	3
2016	1
2017	2
2018	3
2019	1
2020	3
2021	4
2022	3
2024	0

1

Fe(III) and Cu(II) Complexes of Chlorogenic Acid: Spectroscopic, Thermal, Anti-/Pro-Oxidant, and Cytotoxic Studies.

Kalinowska M, Gryko K, Gołębiewska E, Świderski G, Lewandowska H, Pruszyński M, Zawadzka M, Kozłowski M, Sienkiewicz-Gromiuk J, Lewandowski W. Kalinowska M, et al. Among authors: pruszynski m. Materials (Basel). 2022 Oct 1;15(19):6832. doi: 10.3390/ma15196832. Materials (Basel). 2022. PMID: 36234176 Free PMC article.

2

Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer.

Rodak M, Dekempeneer Y, Wojewódzka M, Caveliers V, Covens P, Miller BW, Sevenois MB, Bruchertseifer F, Morgenstern A, Lahoutte T, D'Huyvetter M, Pruszyński M. Rodak M, et al. Among authors: pruszynski m. Mol Cancer Ther. 2022 Dec 2;21(12):1835-1845. doi: 10.1158/1535-7163.MCT-21-1021. Mol Cancer Ther. 2022. PMID: 36129807 Free PMC article.

3

The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy.

Puttemans J, Stijlemans B, Keyaerts M, Vander Meeren S, Renmans W, Fostier K, Debie P, Hanssens H, Rodak M, Pruszynski M, De Veirman K, Vanderkerken K, Lahoutte T, Morgenstern A, Bruchertseifer F, Devoogdt N, D'Huyvetter M. Puttemans J, et al. Among authors: pruszynski m. Mol Cancer Ther. 2022 Jan;21(1):159-169. doi: 10.1158/1535-7163.MCT-21-0220. Epub 2021 Oct 19. Mol Cancer Ther. 2022. PMID: 34667109 Free PMC article.

4

Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy.

Radchenko V, Morgenstern A, Jalilian AR, Ramogida CF, Cutler C, Duchemin C, Hoehr C, Haddad F, Bruchertseifer F, Gausemel H, Yang H, Osso JA, Washiyama K, Czerwinski K, Leufgen K, Pruszyński M, Valzdorf O, Causey P, Schaffer P, Perron R, Maxim S, Wilbur DS, Stora T, Li Y. Radchenko V, et al. Among authors: pruszynski m. J Nucl Med. 2021 Nov;62(11):1495-1503. doi: 10.2967/jnumed.120.261016. Epub 2021 Jul 22. J Nucl Med. 2021. PMID: 34301779 Free PMC article.

5

Crystal Structure, Spectroscopic Characterization, Antioxidant and Cytotoxic Activity of New Mg(II) and Mn(II)/Na(I) Complexes of Isoferulic Acid.

Kalinowska M, Gołębiewska E, Mazur L, Lewandowska H, Pruszyński M, Świderski G, Wyrwas M, Pawluczuk N, Lewandowski W. Kalinowska M, et al. Among authors: pruszynski m. Materials (Basel). 2021 Jun 11;14(12):3236. doi: 10.3390/ma14123236. Materials (Basel). 2021. PMID: 34208366 Free PMC article.

6

Radiochemical separation of ²²⁴Ra from ²³²U and ²²⁸Th sources for ²²⁴Ra/²¹²Pb/²¹²Bi generator.

Pruszyński M, Walczak R, Rodak M, Bruchertseifer F, Morgenstern A, Bilewicz A. Pruszyński M, et al. Appl Radiat Isot. 2021 Jun;172:109655. doi: 10.1016/j.apradiso.2021.109655. Epub 2021 Feb 25. Appl Radiat Isot. 2021. PMID: 33657491

7

Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy.

Gawęda W, Pruszyński M, Cędrowska E, Rodak M, Majkowska-Pilip A, Gaweł D, Bruchertseifer F, Morgenstern A, Bilewicz A. Gawęda W, et al. Among authors: pruszynski m. Nanomaterials (Basel). 2020 Oct 20;10(10):2067. doi: 10.3390/nano10102067. Nanomaterials (Basel). 2020. PMID: 33092037 Free PMC article.

8

Design and Evaluation of ²²³Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part I.

Czerwińska M, Fracasso G, Pruszyński M, Bilewicz A, Kruszewski M, Majkowska-Pilip A, Lankoff A. Czerwińska M, et al. Among authors: pruszynski m. Materials (Basel). 2020 Sep 2;13(17):3875. doi: 10.3390/ma13173875. Materials (Basel). 2020. PMID: 32887308 Free PMC article.

9

Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with ²²⁵Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer.

Cędrowska E, Pruszyński M, Gawęda W, Żuk M, Krysiński P, Bruchertseifer F, Morgenstern A, Karageorgou MA, Bouziotis P, Bilewicz A. Cędrowska E, et al. Among authors: pruszynski m. Molecules. 2020 Feb 25;25(5):1025. doi: 10.3390/molecules25051025. Molecules. 2020. PMID: 32106568 Free PMC article.

10

Trastuzumab-Modified Gold Nanoparticles Labeled with ²¹¹At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer.

Dziawer Ł, Majkowska-Pilip A, Gaweł D, Godlewska M, Pruszyński M, Jastrzębski J, Wąs B, Bilewicz A. Dziawer Ł, et al. Among authors: pruszynski m. Nanomaterials (Basel). 2019 Apr 18;9(4):632. doi: 10.3390/nano9040632. Nanomaterials (Basel). 2019. PMID: 31003512 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year